01:12 PM EDT, 05/29/2026 (MT Newswires) -- Healthcare stocks declined Friday afternoon, with the NYSE Healthcare Index decreasing 0.8% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 0.9%.

The iShares Biotechnology ETF (IBB) rose 0.3%.

In corporate news, AstraZeneca's ( AZN ) Alexion Rare Disease unit said Friday that a phase 3 clinical program evaluating anselamimab in light chain amyloidosis did not meet its primary endpoint in the overall patient population. AstraZeneca ( AZN ) shares were up 0.4%.